How Evaluate Supports Your Success
1
Size market opportunity
Access consensus forecasts for key branded drugs at a European country level. Map future trends of key marketed drugs and pipeline assets. Profile in-line products, identify new assets, and measure their impact on key therapy areas.
2
Scan the R&D horizon
Explore the full pipeline of R&D products launching in the European market. Compare R&D product performance, mapping uptake trends and drivers across key European markets.
3
Compare prices across countries
Analyse ex-factory pricing data for Germany, France, Italy, England, Poland, Spain, and other key markets. Quickly assess new assets using price/DDD benchmark data, and easily carry out comparative analysis across EU-6 countries.
